M&G PLC Purchases Shares of 419,416 Acadia Healthcare Company, Inc. $ACHC

M&G PLC purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 419,416 shares of the company’s stock, valued at approximately $9,647,000. M&G PLC owned 0.46% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Allworth Financial LP grew its holdings in Acadia Healthcare by 676.4% during the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after acquiring an additional 1,177 shares during the period. Campbell & CO Investment Adviser LLC lifted its stake in Acadia Healthcare by 119.0% during the second quarter. Campbell & CO Investment Adviser LLC now owns 74,717 shares of the company’s stock valued at $1,695,000 after purchasing an additional 40,592 shares during the last quarter. Wolverine Asset Management LLC boosted its holdings in Acadia Healthcare by 61.1% during the second quarter. Wolverine Asset Management LLC now owns 49,585 shares of the company’s stock worth $1,125,000 after buying an additional 18,812 shares in the last quarter. Y Intercept Hong Kong Ltd increased its holdings in shares of Acadia Healthcare by 159.6% in the second quarter. Y Intercept Hong Kong Ltd now owns 71,159 shares of the company’s stock valued at $1,615,000 after buying an additional 43,746 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its position in shares of Acadia Healthcare by 54.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 166,880 shares of the company’s stock valued at $3,786,000 after acquiring an additional 58,642 shares during the last quarter.

Analyst Upgrades and Downgrades

ACHC has been the subject of a number of recent analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. UBS Group decreased their target price on shares of Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating for the company in a report on Friday, November 7th. Mizuho cut their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, August 13th. Barclays reduced their price target on shares of Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating for the company in a research report on Thursday, November 6th. Finally, Raymond James Financial set a $22.00 target price on shares of Acadia Healthcare in a research note on Friday, November 7th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $32.82.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $17.41 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. Acadia Healthcare Company, Inc. has a one year low of $17.13 and a one year high of $47.08. The business’s 50-day moving average price is $23.02 and its two-hundred day moving average price is $22.71. The company has a market capitalization of $1.61 billion, a P/E ratio of 11.53, a price-to-earnings-growth ratio of 4.56 and a beta of 0.97.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The business had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. During the same period in the previous year, the company earned $0.91 EPS. The firm’s revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.